---
title: Clobetasone
description: >-
  Clobetasone butyrate is a moderately potent topical corticosteroid prescribed
  for short-term treatment of inflammatory and pruritic manifestations of
  corticosteroid-responsive dermatoses, such as eczema and dermatitis.  It
  belongs to the pharmacological classification of corticosteroids, specific...
is_banned: false
lastModified: '2025-09-22T17:21:52.630Z'
faqs:
  - q: >-
      What is the recommended dosage for Clobetasone?**


      **A:** Adults: Apply a thin layer twice daily for up to 4 weeks. Children
      (12+): Apply a thin layer twice daily for up to 7 days.
    a: >-
      A:** Adults: Apply a thin layer twice daily for up to 4 weeks. Children
      (12+): Apply a thin layer twice daily for up to 7 days.
  - q: >-
      What skin conditions is Clobetasone used for?**


      **A:**  Eczema, dermatitis, and other corticosteroid-responsive
      dermatoses.
    a: 'A:**  Eczema, dermatitis, and other corticosteroid-responsive dermatoses.'
  - q: >-
      Can Clobetasone be used on the face?**


      **A:** Generally avoided unless specifically directed by a physician due
      to increased risk of side effects.
    a: >-
      A:** Generally avoided unless specifically directed by a physician due to
      increased risk of side effects.
  - q: |-
      What are the common side effects of Clobetasone?**

      **A:** Burning or stinging, itching, skin irritation, dryness.
    a: 'A:** Burning or stinging, itching, skin irritation, dryness.'
  - q: >-
      Is Clobetasone safe during pregnancy?**


      **A:** Use only if the potential benefit outweighs the risk.  Consult a
      physician before use.
    a: >-
      A:** Use only if the potential benefit outweighs the risk.  Consult a
      physician before use.
  - q: |-
      How long can I use Clobetasone?**

      **A:**  Maximum 4 weeks for adults, 7 days for children over 12.
    a: 'A:**  Maximum 4 weeks for adults, 7 days for children over 12.'
  - q: |-
      Can Clobetasone be used with occlusive dressings?**

      **A:** No, it is not recommended as it can increase systemic absorption.
    a: 'A:** No, it is not recommended as it can increase systemic absorption.'
  - q: |-
      What should I do if my condition doesn't improve?**

      **A:** Consult a physician.
    a: 'A:** Consult a physician.'
  - q: >-
      What are the signs of an allergic reaction to Clobetasone?**


      **A:**  Severe itching, redness, swelling, blistering, or rash at the
      application site.
    a: >-
      A:**  Severe itching, redness, swelling, blistering, or rash at the
      application site.
  - q: |-
      Can I use Clobetasone for acne?**

      **A:** No, Clobetasone is contraindicated for acne vulgaris.
    a: 'A:** No, Clobetasone is contraindicated for acne vulgaris.'
---
## **Usage**

Clobetasone butyrate is a moderately potent topical corticosteroid prescribed for short-term treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as eczema and dermatitis.  It belongs to the pharmacological classification of corticosteroids, specifically glucocorticoids.  The mechanism of action involves binding to glucocorticoid receptors in the skin, leading to reduced inflammation by suppressing the production and release of inflammatory mediators.

## **Alternate Names**

The international nonproprietary name (INN) is clobetasone butyrate. A common brand name is Eumovate.

## **How It Works**

**Pharmacodynamics:** Clobetasone butyrate exerts its anti-inflammatory, antipruritic, and vasoconstrictive effects by binding to glucocorticoid receptors in the skin cells.  This binding leads to the inhibition of inflammatory pathways, reducing the production of inflammatory cytokines and mediators like prostaglandins and leukotrienes.

**Pharmacokinetics:**  Clobetasone butyrate is applied topically.  Absorption through the skin is minimal under normal conditions, limiting systemic exposure.  However, factors like the skin condition, application site, and use of occlusive dressings can increase absorption. Metabolism primarily occurs in the liver, and elimination is mainly through the kidneys.

**Mode of Action:**  Clobetasone butyrate acts by binding to glucocorticoid receptors in the cytoplasm.  This complex then translocates to the nucleus, where it modulates gene transcription.  This modulation leads to decreased production of inflammatory proteins and increased production of anti-inflammatory proteins.

**Receptor Binding:**  Binds to glucocorticoid receptors.

**Elimination Pathways:** Primarily hepatic metabolism with renal excretion.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

Apply a thin layer to the affected area twice daily. Do not apply to the face, groin, or axillae unless specifically directed by a physician. Treatment should be limited to a maximum of 4 weeks.

#### **Children:**

Use in children under 12 years of age is not recommended unless prescribed by a doctor. For children 12 years and older, apply a thin layer to the affected area twice daily for up to 7 days. If no improvement is observed or if the condition worsens, consult a doctor.

#### **Special Cases:**

* **Elderly Patients:** No specific dosage adjustment is generally required, but initiate with a low dose and titrate cautiously.
* **Patients with Renal Impairment:** Caution is advised, although dose adjustments might not be necessary due to limited systemic absorption.
* **Patients with Hepatic Dysfunction:** Caution is advised, although dose adjustments might not be necessary due to the topical route of administration.
* **Patients with Comorbid Conditions:** Evaluate on a case-by-case basis considering potential interactions with other medical conditions or medications.

### **Clinical Use Cases**

Clobetasone butyrate is not typically indicated for use in scenarios like intubation, surgical procedures, mechanical ventilation, ICU care, or emergency situations. Its use is primarily limited to topical application for dermatological conditions.


### **Dosage Adjustments**

Dosage adjustments may be required in patients with renal or hepatic impairment and should be considered based on patient response and potential drug interactions.


## **Side Effects**

### **Common Side Effects**

* Burning or stinging sensation at the application site (typically transient)
* Itching
* Skin irritation
* Dryness

### **Rare but Serious Side Effects**

* Skin atrophy (thinning)
* Telangiectasia (spider veins)
* Hypopigmentation (skin lightening)
* Hypertrichosis (increased hair growth)
* Striae (stretch marks)
* Allergic contact dermatitis
* Secondary infections

### **Long-Term Effects**

Prolonged use can lead to skin atrophy, telangiectasia, striae, and HPA axis suppression (with systemic absorption).

### **Adverse Drug Reactions (ADR)**

Severe allergic reactions, although rare, can occur and require immediate discontinuation of the drug.

## **Contraindications**

* Hypersensitivity to clobetasone butyrate
* Untreated skin infections (bacterial, viral, fungal)
* Rosacea
* Acne vulgaris
* Perioral dermatitis

## **Drug Interactions**

Clinically significant drug interactions are rare due to limited systemic absorption. However, concomitant use of strong CYP3A4 inhibitors (e.g., ritonavir, itraconazole) may increase systemic exposure.

## **Pregnancy and Breastfeeding**

Use during pregnancy and breastfeeding should only be considered if the potential benefit to the mother outweighs the risk to the fetus or infant.  If used during lactation, avoid applying to the breast area.


## **Drug Profile Summary**

* **Mechanism of Action:**  Binds to glucocorticoid receptors, reducing inflammation.
* **Side Effects:** Burning/stinging, itching, skin irritation, atrophy, telangiectasia.
* **Contraindications:** Hypersensitivity, infections, rosacea, acne.
* **Drug Interactions:** CYP3A4 inhibitors.
* **Pregnancy & Breastfeeding:** Use with caution if benefits outweigh risks.
* **Dosage:** Apply thinly twice daily, maximum 4 weeks for adults, 7 days for children over 12.
* **Monitoring Parameters:** Monitor for local skin reactions and signs of systemic absorption (e.g., HPA axis suppression).

## **Popular Combinations**

Clobetasone butyrate is not typically used in combination with other topical medications.


## **Precautions**

* Avoid prolonged use.
* Avoid use on the face, groin, or axillae unless directed by a physician.
* Monitor for skin atrophy and other local side effects.
* Use with caution in pediatric and geriatric patients.
* Avoid abrupt withdrawal.

## **FAQs (Frequently Asked Questions)**


### **Q1: What is the recommended dosage for Clobetasone?**

**A:** Adults: Apply a thin layer twice daily for up to 4 weeks. Children (12+): Apply a thin layer twice daily for up to 7 days.

### **Q2: What skin conditions is Clobetasone used for?**

**A:**  Eczema, dermatitis, and other corticosteroid-responsive dermatoses.

### **Q3: Can Clobetasone be used on the face?**

**A:** Generally avoided unless specifically directed by a physician due to increased risk of side effects.

### **Q4: What are the common side effects of Clobetasone?**

**A:** Burning or stinging, itching, skin irritation, dryness.

### **Q5: Is Clobetasone safe during pregnancy?**

**A:** Use only if the potential benefit outweighs the risk.  Consult a physician before use.

### **Q6: How long can I use Clobetasone?**

**A:**  Maximum 4 weeks for adults, 7 days for children over 12.

### **Q7: Can Clobetasone be used with occlusive dressings?**

**A:** No, it is not recommended as it can increase systemic absorption.

### **Q8: What should I do if my condition doesn't improve?**

**A:** Consult a physician.

### **Q9:  What are the signs of an allergic reaction to Clobetasone?**

**A:**  Severe itching, redness, swelling, blistering, or rash at the application site.

### **Q10: Can I use Clobetasone for acne?**

**A:** No, Clobetasone is contraindicated for acne vulgaris.
